Bristol Myers Squibb (BMY) Change in Taxes (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Change in Taxes for 18 consecutive years, with -$522.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Taxes rose 15.94% year-over-year to -$522.0 million in Q2 2026; TTM through Jun 2026 was $228.0 million, a 128.72% increase from a year earlier, with the FY2025 full-year figure at -$4.0 million, up 99.68% from the prior year.
• Change in Taxes was -$522.0 million for Q2 2026 at Bristol Myers Squibb, down from $187.0 million in the prior quarter.
• Over five years, Change in Taxes peaked at $1.0 billion in Q4 2023 and troughed at -$2.1 billion in Q2 2023.
• A 5-year average of -$201.4 million and a median of -$135.0 million in 2025 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes plunged 786.67% in 2023 and jumped 354.89% in 2025, its largest moves.
• Over 5 years, Change in Taxes stood at -$1.1 billion in 2022, then surged by 193.8% to $1.0 billion in 2023, then slumped by 88.41% to $121.0 million in 2024, then plunged by 367.77% to -$324.0 million in 2025, then sank by 61.11% to -$522.0 million in 2026.
• The last three Change in Taxes figures came in at -$522.0 million (Q2 2026), $187.0 million (Q1 2026), and -$324.0 million (Q4 2025), per Business Quant data.